Literature DB >> 20583080

Improvement in hepatopulmonary syndrome after methadone withdrawal: a case report with implications for disease mechanism.

Edmund M T Lau1, Geoffrey McCaughan, Paul J Torzillo.   

Abstract

Spontaneous resolution of hepatopulmonary syndrome (HPS) without liver transplantation or improvement in the underlying liver disease has rarely been reported in the literature. Increased endogenous production of nitric oxide has been implicated in the pathogenesis of HPS. We report the case of a 50-year-old man with hepatitis C cirrhosis who demonstrated dramatic improvement in HPS after withdrawal from chronic methadone therapy. We speculate on the potential role of opiate receptors in the pulmonary vasculature and their effect on nitric oxide signaling as a potential mechanism accounting for the patient's clinical improvement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583080     DOI: 10.1002/lt.22081

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  3 in total

1.  Protective effect of nitric oxide on hepatopulmonary syndrome from ischemia-reperfusion injury.

Authors:  Tong-Jin Diao; Xin Chen; Li-Hua Deng; Han-Xiang Chen; Yan Liang; Xiao-Dong Zhao; Qing-Hua Wang; Wei-Sheng Yuan; Bai-Chun Gao; Yong Ye
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

Review 2.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

3.  Effects of Reduced Nicotine Content Cigarettes on Fractional Exhaled Nitric Oxide and Self-Reported Respiratory Health Outcomes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage.

Authors:  Anthony C Oliver; Michael DeSarno; Charles G Irvin; David Kaminsky; Jennifer W Tidey; Stacey C Sigmon; Sarah H Heil; Diann E Gaalema; Dustin Lee; Janice Y Bunn; Danielle R Davis; Joanna M Streck; Thomas Gallagher; Stephen T Higgins
Journal:  Nicotine Tob Res       Date:  2022-01-01       Impact factor: 5.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.